These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3494820)

  • 21. [Clinical studies of adoptive immunotherapy of human disseminated brain tumors with LAK cells and recombinant interleukin-2].
    Okamoto Y; Shimizu K; Miyao Y; Yamada M; Ushio Y; Matsui Y; Hayakawa T; Tago H; Ikeda H
    No To Shinkei; 1986 Jun; 38(6):593-8. PubMed ID: 3488068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor.
    Ichino Y; Ishikawa T
    Gan; 1984 May; 75(5):436-41. PubMed ID: 6235143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage immunotherapy of malignant glioma.
    Ingram M; Jacques S; Freshwater DB; Techy GB; Shelden CH; Helsper JT
    Arch Surg; 1987 Dec; 122(12):1483-6. PubMed ID: 3500693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial-capillary-system development of human alloreactive cytotoxic T-lymphocytes that lyse brain tumours.
    Kruse CA; Beck LT
    Biotechnol Appl Biochem; 1997 Jun; 25(3):197-205. PubMed ID: 9198273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human interleukin-2 activated cytotoxic cells kill autologous glioma cells in vitro.
    Bosnes V; Hirschberg H
    J Neurooncol; 1988; 6(1):85-92. PubMed ID: 3260942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.
    Miyatake S; Nishihara K; Kikuchi H; Yamashita J; Namba Y; Hanaoka M; Watanabe Y
    J Natl Cancer Inst; 1990 Feb; 82(3):217-20. PubMed ID: 2104938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scintigraphy with In-111 labeled lymphokine-activated killer cells of malignant brain tumor.
    Itoh K; Sawamura Y; Hosokawa M; Kobayashi H
    Radiat Med; 1988; 6(6):276-81. PubMed ID: 2854899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy.
    Liu G; Akasaki Y; Khong HT; Wheeler CJ; Das A; Black KL; Yu JS
    Oncogene; 2005 Aug; 24(33):5226-34. PubMed ID: 15897911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor.
    Yamasaki T; Handa H; Yamashita J; Namba Y; Watanabe Y; Kuwata S; Hanaoka M
    J Neurosurg; 1984 May; 60(5):998-1004. PubMed ID: 6201598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
    Grimm EA
    Prog Clin Biol Res; 1987; 244():185-95. PubMed ID: 3498948
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.
    Fujita M; Zhu X; Sasaki K; Ueda R; Low KL; Pollack IF; Okada H
    J Immunol; 2008 Feb; 180(4):2089-98. PubMed ID: 18250414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells.
    Jacob L; Somasundaram R; Smith W; Monos D; Basak S; Marincola F; Pereira S; Herlyn D
    Int J Cancer; 1997 May; 71(3):325-32. PubMed ID: 9139862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.
    Guarini A; Gansbacher B; Cronin K; Fierro MT; Foa R
    Cytokines Mol Ther; 1995 Mar; 1(1):57-64. PubMed ID: 9384664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CTL precursor-oriented peptide vaccine therapy for malignant glioma].
    Yajima N; Yamanaka R; Tanaka R; Shigemori M; Mine T; Itoh K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():582-7. PubMed ID: 16201585
    [No Abstract]   [Full Text] [Related]  

  • 36. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.
    Jacobs SK; Wilson DJ; Kornblith PL; Grimm EA
    Cancer Res; 1986 Apr; 46(4 Pt 2):2101-4. PubMed ID: 3512079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An experimental approach to specific adoptive immunotherapy for malignant brain tumors.
    Yamasaki T; Kikuchi H
    Nihon Geka Hokan; 1989 Nov; 58(6):485-92. PubMed ID: 2519184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolysis of autologous fresh osteosarcoma cells by human cytotoxic T lymphocytes propagated with T cell growth factor.
    Ichino Y; Ishikawa T
    Gan; 1983 Aug; 74(4):584-94. PubMed ID: 6605270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.
    Slingluff CL; Darrow TL; Seigler HF
    Ann Surg; 1989 Aug; 210(2):194-202. PubMed ID: 2787972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.